Drug
Blink tears
Blink tears is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
100%(4 trials)
Phase Distribution
Ph not_applicable
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completed
Clinical Evaluation of an Investigational Lipid Drop in Non-contact Lens Wearing Patients
NCT03995355
completednot_applicable
Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms
NCT00565669
completednot_applicable
Efficacy and Safety Study of FID 119515A
NCT01833117
completednot_applicable
Acute Comfort and Blurring Profile Evaluation of Marketed Lubricant Eye Drops
NCT00756093
Clinical Trials (4)
Showing 4 of 4 trials
NCT03995355
Clinical Evaluation of an Investigational Lipid Drop in Non-contact Lens Wearing Patients
NCT00565669Not Applicable
Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms
NCT01833117Not Applicable
Efficacy and Safety Study of FID 119515A
NCT00756093Not Applicable
Acute Comfort and Blurring Profile Evaluation of Marketed Lubricant Eye Drops
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4